MGTX: MeiraGTx Holdings Plc
About
MeiraGTx Holdings Plc engages in the development of novel gene therapy treatments. The company was founded on March 20, 2015 and is headquartered in New York, NY.
Current Value
$5.931 Year Return
Current Value
$5.931 Year Return
Key Details
Market Cap
$467.36M
P/E Ratio
-4.58
1Y Stock Return
9.12%
1Y Revenue Growth
0.00%
Dividend Yield
0.00%
Price to Book
4.9
Strategies that include MGTX
Stock's related to MGTX
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| NTLA | 49.96% | $1.44B | -50.35% | 0.00% |
| BEAM | 48.17% | $2.09B | -9.52% | 0.00% |
| CRSP | 46.12% | $4.01B | -30.49% | 0.00% |
| EDIT | 45.88% | $204.72M | -75.49% | 0.00% |
| CPRX | 45.65% | $2.55B | +55.68% | 0.00% |
| NXDT | 44.38% | $218.01M | -37.42% | 11.58% |
| ACLX | 43.93% | $4.74B | +69.19% | 0.00% |
| CRBU | 43.65% | $180.20M | -62.45% | 0.00% |
| ABCL | 43.04% | $800.44M | -37.56% | 0.00% |
| VIR | 42.89% | $954.40M | -26.51% | 0.00% |
| CLNE | 42.12% | $589.93M | -23.92% | 0.00% |
| BIGC | 42.09% | $473.42M | -31.75% | 0.00% |
| DDD | 41.18% | $402.06M | -35.13% | 0.00% |
| ADPT | 41.17% | $661.15M | +6.16% | 0.00% |
| GPRO | 41.09% | $179.52M | -67.23% | 0.00% |
| PGEN | 41.06% | $228.91M | -28.00% | 0.00% |
| MCFT | 41.03% | $344.65M | -0.29% | 0.00% |
| RCKT | 40.96% | $1.20B | -39.83% | 0.00% |
| HCAT | 40.94% | $458.79M | 0.00% | 0.00% |
| JOUT | 40.63% | $328.98M | -37.36% | 4.09% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MSDL | -0.08% | $1.83B | +0.66% | 7.26% |
| PRPH | -0.10% | $18.14M | -82.61% | 0.00% |
| WHLM | 0.11% | $17.64M | -29.34% | 0.00% |
| OXBR | 0.16% | $19.05M | +178.18% | 0.00% |
| CCEC | 0.21% | $1.02B | +28.03% | 3.26% |
| STVN | 0.30% | $4.95B | -32.48% | 0.32% |
| UNM | 0.39% | $13.16B | +69.20% | 2.16% |
| FTNT | -0.40% | $69.59B | +72.67% | 0.00% |
| IMNN | -0.52% | $10.02M | -22.89% | 0.00% |
| XGN | -0.55% | $62.26M | +127.74% | 0.00% |
| LITB | 0.58% | $35.48M | -75.45% | 0.00% |
| AON | 0.78% | $82.00B | +16.33% | 0.70% |
| ADP | -0.99% | $121.23B | +28.69% | 1.89% |
| ZCMD | 1.07% | $2.80M | -88.67% | 0.00% |
| KNOP | 1.08% | $210.40M | +11.75% | 1.68% |
| NEUE | 1.09% | $40.93M | -34.13% | 0.00% |
| TCTM | -1.13% | $8.10M | -42.99% | 0.00% |
| HIHO | -1.20% | $8.63M | 0.00% | 6.12% |
| CBOE | 1.24% | $21.46B | +15.84% | 1.11% |
| RSG | 1.31% | $66.05B | +31.79% | 1.04% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| HUSA | -10.90% | $16.69M | -11.56% | 0.00% |
| FATBB | -9.37% | $81.94M | -12.91% | 11.69% |
| IBKR | -8.54% | $20.20B | +131.83% | 0.37% |
| VIST | -7.86% | $4.75B | +67.10% | 0.00% |
| MNOV | -6.22% | $93.19M | +2.15% | 0.00% |
| CYD | -5.39% | $364.46M | -2.94% | 4.26% |
| CHD | -5.36% | $27.18B | +19.50% | 1.03% |
| TXO | -5.34% | $737.26M | -1.80% | 13.22% |
| VIRT | -5.15% | $3.17B | +110.38% | 2.60% |
| MCK | -4.81% | $78.15B | +35.51% | 0.42% |
| BTCT | -4.61% | $42.61M | +353.33% | 0.00% |
| PAYX | -4.60% | $50.62B | +18.84% | 2.73% |
| COR | -4.33% | $47.48B | +21.20% | 0.86% |
| TPST | -4.18% | $37.75M | -77.59% | 0.00% |
| EW | -3.47% | $41.40B | +4.84% | 0.00% |
| IMRN | -3.15% | $10.31M | -5.04% | 0.00% |
| PGR | -3.14% | $149.10B | +57.29% | 0.45% |
| ALL | -2.78% | $52.06B | +45.67% | 1.85% |
| QXO | -2.56% | $6.51B | -35.95% | 0.00% |
| KSPI | -1.75% | $20.86B | +18.06% | 3.37% |
ETF's related to MGTX
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| QQA | 57.56% | $135.01M | 0% |
| GNOM | 56.13% | $70.59M | 0.5% |
| IWC | 55.80% | $933.99M | 0.6% |
| ARKG | 54.80% | $1.13B | 0.75% |
| XPH | 54.15% | $157.87M | 0.35% |
| XBI | 53.02% | $6.58B | 0.35% |
| IBB | 52.50% | $6.66B | 0.45% |
| RSPA | 52.24% | $273.87M | 0% |
| IWM | 51.79% | $75.73B | 0.19% |
| VTWO | 51.76% | $12.38B | 0.1% |
| PBE | 51.23% | $258.53M | 0.58% |
| FBT | 51.04% | $1.11B | 0.56% |
| VIOV | 50.87% | $1.44B | 0.15% |
| IWO | 50.84% | $12.56B | 0.24% |
| IWN | 50.61% | $13.17B | 0.24% |
| IJS | 50.33% | $7.37B | 0.18% |
| KOMP | 50.30% | $2.09B | 0.2% |
| NUSC | 50.16% | $1.27B | 0.31% |
| PRFZ | 50.15% | $2.65B | 0.39% |
| ESML | 49.85% | $1.90B | 0.17% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| HDRO | 0.11% | $164.26M | 0.3% |
| CANE | -0.12% | $17.72M | 0.29% |
| HIGH | -0.15% | $302.78M | 0.51% |
| UNG | -0.29% | $908.80M | 1.06% |
| XBIL | -0.73% | $637.70M | 0.15% |
| SOYB | 0.92% | $27.32M | 0.22% |
| DBMF | 0.97% | $1.02B | 0.85% |
| SHV | 1.05% | $18.13B | 0.15% |
| KRBN | 1.12% | $242.47M | 0.85% |
| FMF | -1.28% | $244.61M | 0.95% |
| JUCY | -1.65% | $324.29M | 0.6% |
| BSCO | 1.68% | $2.35B | 0.1% |
| CORN | -2.02% | $61.12M | 0.2% |
| XHLF | -2.07% | $874.27M | 0.03% |
| JPST | 2.11% | $28.43B | 0.18% |
| FLTR | 2.35% | $1.79B | 0.14% |
| GBIL | 2.58% | $5.60B | 0.12% |
| TBIL | -2.88% | $4.38B | 0.15% |
| FBY | 3.06% | $127.69M | 0.99% |
| USCI | 3.14% | $185.47M | 1.07% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -40.82% | $388.04M | 1.43% |
| VIXY | -24.03% | $195.31M | 0.85% |
| USDU | -22.95% | $201.97M | 0.5% |
| UUP | -18.88% | $309.25M | 0.77% |
| CTA | -14.58% | $350.27M | 0.78% |
| AGZD | -13.70% | $142.76M | 0.23% |
| DBO | -9.69% | $217.57M | 0.77% |
| KMLM | -8.90% | $353.87M | 0.9% |
| TAIL | -7.24% | $67.98M | 0.59% |
| EQLS | -7.03% | $76.08M | 1% |
| DBE | -6.78% | $50.13M | 0.77% |
| KCCA | -5.92% | $220.51M | 0.87% |
| BOXX | -5.59% | $4.43B | 0.1949% |
| MINT | -5.29% | $11.62B | 0.35% |
| CLOI | -5.13% | $715.40M | 0.4% |
| WEAT | -4.80% | $120.27M | 0.28% |
| BILZ | -4.21% | $563.02M | 0.14% |
| SGOV | -3.82% | $27.53B | 0.09% |
| DBA | -3.79% | $755.88M | 0.93% |
| TBIL | -2.88% | $4.38B | 0.15% |
News
Yahoo
Shareholders might have noticed that MeiraGTx Holdings plc ( NASDAQ:MGTX ) filed its quarterly result this time last...
Yahoo
MeiraGTx (MGTX) delivered earnings and revenue surprises of -14.89% and 4,264%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Yahoo
Received 3 Rare Pediatric Disease Designations (RPDD) from FDA for each of 3 potential therapies for 3 different rare inherited retinopathies including AAV-AIPL1 Agreed on pathway with MHRA for Marketing Authorization Application (MAA) under exceptional circumstances for AAV-AIPL1 for the treatment of Leber congenital amaurosis (LCA4) retinal dystrophy without further clinical studies Announced positive data from randomized, sham-controlled clinical bridging study of AAV-GAD for the treatment of
Finnhub
MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates - ...
Yahoo
Multiple Posters Highlight the Breadth of Company’s Novel Genetic Medicine and Cell Therapy PlatformsLONDON and NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced the Company will exhibit five posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress, which is being held from October 22-25, 2024, in Rome, Italy. The posters are available on the Posters and
Yahoo
The United States market has remained flat over the last week but is up 38% over the past year with earnings expected to grow by 15% annually. In this context, high growth tech stocks that exhibit robust innovation and scalability potential are particularly noteworthy as they can capitalize on these favorable economic conditions.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.